About the Startup
Stockholm-based biotech focused on industrial-scale production of GMP-certified mesenchymal stem cells (MSCs) for research and clinical use, aiming to lower costs and expand access to high-quality allogeneic MSCs.
Frequently Asked Questions
What type of funding round did Cellcolabs raise?
Cellcolabs raised a unspecified round.
How much did Cellcolabs raise in its unspecified?
Cellcolabs raised $12,000,000 USD in its unspecified.
When did Cellcolabs raise its unspecified?
Cellcolabs raised its unspecified on 2025-10-28.
Who invested in Cellcolabs's unspecified?
The investors in Cellcolabs's unspecified are: Titian Life Sciences.
What type of investment was Cellcolabs's unspecified?
Cellcolabs's unspecified was a equity investment.